All of these patients also had germline variants in PRKAR1A, raising the possibility that PDE11A variants act as genetic modifiers that elevate the risk for PPNAD and/or LCCSCT in CNC. The gene discussed is PRKAR1A; the disease is primary pigmented nodular adrenocortical disease.